Global Pharma Giants Tackle U.S. Tariff Threats Amid Health Developments
Published on: Sept. 27, 2025, 2:30 a.m. | Source: Devdiscourse
Recent health news highlights the detection of screwworm in Mexico due to U.S. protocols, the U.K.'s push against U.S. pharma tariffs, AstraZeneca's discounts on drugs, and Trump's controversial medical claims. Moreover, global drugmakers, including Sanofi and Novartis, respond to potential U.S. tariffs with strategic investments.
